Risk reduction with long-term clopidogrel following percutaneous coronary intervention [3] (multiple letters)

European Heart Journal

Volumn 25, Issue 23, 2004, Pages 2169-2171

  Steinhubl, Steven R ^a   Topol, Eric J ^a,b   Eriksson, Peter ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; HEART DEATH; HEART INFARCTION; HUMAN; LETTER; LONG TERM CARE; PRIORITY JOURNAL; RISK REDUCTION; STATISTICAL SIGNIFICANCE; STROKE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; RISK REDUCTION BEHAVIOR; TICLOPIDINE;

EID: 9644253130     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.08.011     Document Type: Letter

References (0)